MedPath

Effect of hypertonic saline on fluid requirement during major abdominal surgery.

Completed
Conditions
Other Procedures,
Registration Number
CTRI/2019/09/021032
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

This prospective randomised control trial will seek to evaluate whether 3% hypertonic saline will reduce intra operative maintenance fluid requirement in patients undergoing major abdominal surgeries in comparison with normal saline. The study will comprise of 100 patients who will be divided into two groups;group 1 will receive 3% hypertonic saline via wide bore cannula at the rate of 1ml/kg/hr and group 2 will receive normal saline at the rate of 1ml/kg/hr. Both the groups will receive maintenance fluid to maintain a target of MAP>75mmHg, urine output of 0.5-1ml/kg/hr and CVP >8-10mmHg(wherever monitored). Primary outcome will be difference in intra operative maintenance fluid requirement.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients of ASA1 and ASA2 2.
  • Surgeries lasting more than 2 hours 3.
  • Expected hospital stay of more than 3 days.
Exclusion Criteria
  • Patients refusal to give consent 2.
  • Inoperability 3.
  • Emergency 4.
  • Disturbances in serum sodium levels 5.
  • Baseline elevated serum creatinine 6.
  • Laproscopy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference in intraoperative maintenance fluid requirementsIntraoperative
Secondary Outcome Measures
NameTimeMethod
1.Difference in 24hr fluid requirement2. Need of vasopressors in 24hrs

Trial Locations

Locations (1)

All India Institute of Medical Sciences

🇮🇳

Khordha, ORISSA, India

All India Institute of Medical Sciences
🇮🇳Khordha, ORISSA, India
Dr Shri Hari Priya Behera
Principal investigator
7681826136
priya.bhr@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.